Complete Genomics competitors

Stephen R. Davis is a Chief Executive Officer & Board Member at ACADIA PHARMACEUTICALS INC.

John 'Chip' Scarlett is a Co-Founder at Covance and Board Member at CYTOMX THERAPEUTICS, INC. and is based in Menlo Park, California. He has worked as Board Member at GERON CORP, Board Member at Chiasma Inc, and Adjunct Assistant Professor of Medicine at Hospital of the University of Pennsylvania. John works or has worked as Various Positions at Mcneil Pharmaceuticals and Dir:Medical Research & Svcs at Mcneil Pharmaceuticals. He studied at University of Colorado Boulder between 1980 and 1982, University of Chicago - The Pritzker School of Medicine between 1973 and 1977, and Earlham College between 1969 and 1973.

Francis Aurelio deSouza (born December 2, 1970) is an American entrepreneur and business executive. He is the president and chief executive officer (CEO) of Illumina and a member of the Board of Directors of The Walt Disney Company.

Douglas C. Bryant became President and Chief Executive Officer on March 1, 2009. Prior to joining Quidel, Mr. Bryant served as Executive Vice President and Chief Operating Officer at Luminex Corporation, managing its Bioscience Group, Luminex Molecular Diagnostics (Toronto), manufacturing, R&D, technical operations, and commercial operations. From 1983 to 2007, he held various worldwide commercial operations positions with Abbott Laboratories including, among others: Vice President of Abbott Vascular for Asia/Japan, Vice President of Abbott Molecular Global Commercial Operations and Vice President of Abbott Diagnostics Global Commercial Operations. Earlier in his career with Abbott, Mr. Bryant was Vice President of Diagnostic Operations in Europe, the Middle East and Africa, and Vice President of Diagnostic Operations Asia Pacific. Mr. Bryant holds a B.A. in Economics from the University of California at Davis.

Bill joined KeyW from XLA, a technology firm, which supports the federal government in areas of national security and diplomacy, where he served as president and chief operating officer. Prior to XLA, he served as president of Kaseman, a professional services firm supporting the U.S. government in nation building and foreign policy assistance. Before that, he was senior vice president at GTSI Corporation, a technology provider to the U.S. government. At GTSI Corporation, Bill launched and developed a professional services business, which accounted for one quarter of the company's revenue and one third of its profit. He has also held senior executive positions, each focused on generating new solutions and growth, with McData, CNT Corporation, Inrange Technologies, International Network Services and AT&T. Bill holds a Bachelor of Science degree from Washington University and is a graduate of The Executive Program at the University of Virginia Darden School of Business. He is a former U.S. Army Officer and Airborne Ranger.

Juan Ramón Alaix was appointed chief executive officer of Zoetis in July 2012. In this role, he leads the world’s largest company with a singular focus on animal health medicines and vaccines. He is a member of the Zoetis Board of Directors. Mr. Alaix served as President of Pfizer Animal Health since 2006, where he was responsible for the overall strategic direction and financial performance of the company. Under his leadership, the company generated annual revenue of $4.8 billion in 2015 with approximately 9,000 employees worldwide. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. He joined Pfizer from Pharmacia in 2003 as Regional President. He has 35 years’ experience of increasing responsibility in finance, commercial and management, including 20 years in the pharmaceutical industry. In the 1990s, Mr. Alaix served in general management with Rhône-Poulenc Rorer in Spain and Belgium before becoming country President of Spain for Pharmacia in 1998. In 2013, Mr. Alaix completed a two-year term as President of the International Federation for Animal Health (IFAH), now known as HealthforAnimals, in addition to serving as a member of the board and executive committee. HealthforAnimals represents manufacturers of veterinary medicines, vaccines and other animal health products in both developed and emerging markets. Mr. Alaix continues to serve as a member of the HealthforAnimals board and executive committee. A native of Spain, Mr. Alaix received a graduate degree in economics from the Universidad de Madrid.

Mr. ElSawy has been the Chief Executive of Noblis since October 2007 and serves as the President responsible for the general management and strategic direction of its overall scientific, technical, financial, and administrative activities. He was elected to the Noblis, Inc. (Noblis) Board of Trustees in 2007. Mr. ElSawy has extensive experience leading organizations and developing innovative solutions to some of the most complex challenges facing public sector enterprises in the following domains: national security, transportation, health, and the environment. His work experience includes research and development, complex engineering of information and telecommunications systems, modeling and simulation, enterprise transformation using cloud and high performance computing, program management and acquisition of large scale systems. He has also earned an international reputation as a leader in aviation; informing domestic and international aviation policy. Under his leadership as President & CEO, Noblis was selected several times as a Top Employer by the Washington Post, selected as one of the “50 Best Small and Mid-size Companies to Work for in America,” and named one of the “World’s Most Ethical” companies by the Ethisphere Institute. Prior to joining Noblis, Mr. ElSawy was a Senior Vice President and General Manager of the Center for Advanced Aviation System Development of The MITRE Corporation. Mr. ElSawy served for seven years as the Director of the Federally Funded Research and Development Center (FFRDC) for the FAA. Mr. ElSawy holds a Master’s Degree in Business Administration from Georgetown University, a Master’s Degree in Electrical Engineering from The George Washington University, and a Bachelor’s Degree in Electrical Engineering from West Virginia University. In 2009, Mr. ElSawy was named EcoCEO by SmartCEO magazine and was named to the Washingtonian Tech Titan list multiple times. In 2012, he was elected to the George Washington University Engineering Hall of Fame and in 2016 he was selected to the Wash100 by Executive Mosaic. Mr. ElSawy currently serves as a Board Member of the Northern Virginia Technology Council (NVTC), and a Board of Trustees member of George Washington University.